{
  "meta": {
    "title": "Pph",
    "url": "https://brainandscalpel.vercel.app/pph-5cfb25db.html",
    "scrapedAt": "2025-11-30T08:49:48.167Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">HR/SBP</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">HR/MAP</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">HR/DBP</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">SBP/HR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The formula for Obstetric shock index:</span></p>",
      "unique_key": "DT1289160",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The <strong>Obstetric Shock Index</strong> is calculated using the formula:</p>\r\n<ol>\r\n<li><strong> HR/SBP</strong> (Heart Rate divided by Systolic Blood Pressure)</li>\r\n</ol>\r\n<p>Here's why:</p>\r\n<ul>\r\n<li><strong>HR</strong> stands for Heart Rate.</li>\r\n<li><strong>SBP</strong> stands for Systolic Blood Pressure.</li>\r\n</ul>\r\n<p>The Shock Index is used to assess the severity of shock by comparing the heart rate to the systolic blood pressure. <em>An elevated Shock Index (typically greater than 0.9) can indicate significant hemodynamic compromise</em> and may be used to guide further evaluation and management in obstetric emergencies.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120569b4d0c1-95e7-403e-914e-559c4d27fa86.jpg\">\r\n<p><strong>Reference:</strong> RCOG Green Top Guideline no. 52 Prevention and Management of Postpartum Haemorrhage</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Atonic PPH</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Traumatic PPH</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Retained placenta</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Coagulation disorders</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">2nd most common cause of PPH:</span></p>",
      "unique_key": "DT1289333",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289333,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>2nd M/C cause of PPH is Genital tract trauma, the <em>first being Atonic PPH.</em></strong></p>\r\n<p><strong>OPTION A) Atonic PPH</strong></p>\r\n<ul>\r\n<li><strong>Explanation:</strong> <em>Atonic PPH is the most common cause of postpartum hemorrhage.</em> It occurs when the uterus fails to contract effectively after childbirth, leading to excessive bleeding. It is <em>often managed with uterotonics </em>and other interventions to stimulate uterine contraction.</li>\r\n</ul>\r\n<p><strong>OPTION B) Traumatic PPH</strong></p>\r\n<ul>\r\n<li><strong>Explanation:</strong> Traumatic PPH refers to bleeding caused by trauma to the birth canal, such as lacerations or tears in the cervix, vagina, or perineum. This is considered the second most common cause of PPH, especially if the trauma is not promptly identified and repaired.</li>\r\n</ul>\r\n<p><strong>OPTION C) Retained Placenta</strong></p>\r\n<ul>\r\n<li><strong>Explanation:</strong> Retained placenta occurs when the placenta or parts of it are left inside the uterus after delivery, <em>preventing the uterus from contracting properly.</em> This condition can lead to significant bleeding and <em>usually requires manual removal or surgical intervention.</em></li>\r\n</ul>\r\n<p><strong>OPTION D) Coagulation Disorders</strong></p>\r\n<ul>\r\n<li><strong>Explanation:</strong> Coagulation disorders, such as disseminated intravascular coagulation (DIC) or inherited bleeding disorders, can lead to abnormal bleeding and contribute to postpartum hemorrhage. <em>These conditions are less common but can be severe</em> and require specific treatment to manage bleeding.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>Four basic pathologies are expressed as the 4 T's (RCOG):</p>\r\n<ol>\r\n<li><strong>Tone (atonicity)</strong></li>\r\n<li><strong>Tissue (retained bits, blood clots)</strong></li>\r\n<li><strong>Trauma (genital tract injury)</strong></li>\r\n<li><strong>Thrombin (coagulopathy)</strong></li>\r\n</ol>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Pudendal artery</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal artery</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Descending cervical artery</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior gluteal artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21 year old primigravida has a prolonged 2nd stage of labour. She delivers a macrosomic baby, has a wide episiotomy, which was stitched by the resident. Few hours later, she complains of severe perineal pain, and is unable to void urine. She is 2+ pale, with tachycardia. The consultant diagnoses a vulvar hematoma on examination. Which of the following is the most common artery involved?</span></p>",
      "unique_key": "DT1289334",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289334,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Depending upon the location of the hematoma, whether below or above the levator ani, it is termed as:</strong></p>\r\n<ul>\r\n<li>Infralevator hematoma-common</li>\r\n<li>Supralevator hematoma-rare</li>\r\n</ul>\r\n<p>INFRALEVATOR HEMATOMA: The commonest one is the vulval hematoma.</p>\r\n<p><strong>Etiology:</strong></p>\r\n<ol>\r\n<li>Improper hemostasis during repair of vaginal or perineal tears or episiotomy wound- (a) Failure to take precaution while suturing the apex of the tear (b) Failure to obliterate the dead space while suturing the vaginal walls.</li>\r\n<li>Rupture of paravaginal venous plexus either spontaneously or following instrumental delivery.</li>\r\n</ol>\r\n<p>Treat by draining the hematoma and resuturing the episiotomy.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>(1) Persistent, severe pain on the perineal region.</p>\r\n<p>(2) There may be rectal tenesmus or bearing down efforts when extension occurs to the ischiorectal fossa. There may be even retention of urine.</p>\r\n<p>(2) Local examination reveals a tense swelling at the vulva which becomes dusky and purple in color and tender to touch.</p>\r\n<p><strong>M/C artery to form vulvar hematoma-Pudendal Artery</strong></p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Hb >7 gm/dl</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet count >75000/ul</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">PT <1.5 x mean control</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrinogen >1g/dl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Recommendations for maintaining hematological parameters in massive haemorrhage are all except:</span></p>",
      "unique_key": "DT1289335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>All other are recommended by British Committee of Standards in hematology.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p><em>British committee of standards in hematology recommendations </em>for maintaining coagulation parameters in massive haemorrhage</p>\r\n<ul>\r\n<li><strong>Haemoglobin &gt; 8 g/dl</strong></li>\r\n<li><strong> Platelet count &gt; 75 &times; 109</strong></li>\r\n<li><strong> Fibrinogen &gt; 1.0 g/dl</strong></li>\r\n<li><strong> Prothrombin &lt; 1.5 x mean control &amp; APTT &lt; 1.5 x mean control</strong></li>\r\n</ul>\r\n<p><strong>Reference:</strong> RCOG Green Top Guideline no. 52 Prevention and Management of Postpartum Haemorrhage</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Preeclampsia</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Preterm labour</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">PPH</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes in pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Rule of 30 is used in management of:</span></p>",
      "unique_key": "DT1289337",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289337,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>The Rule of 30 is used to guide the management of PPH. It involves giving 30 units of oxytocin (or its equivalent) to manage uterine atony, a common cause of PPH.</em></p>\r\n<p><strong>Option a) Preeclampsia:</strong> The management involves blood pressure control, magnesium sulfate for seizure prophylaxis, and timely delivery. The Rule of 30 is not specifically applied here.</p>\r\n<p><strong>Option b) Preterm labor:</strong> Management focuses on tocolytics, corticosteroids for fetal lung maturity, and possible transfer to a facility with neonatal intensive care. The Rule of 30 does not pertain to this condition.</p>\r\n<p><strong>Postpartum hemorrhage (PPH): Option d) Diabetes in pregnancy:</strong> Management involves blood glucose control, monitoring, and possibly insulin therapy. The Rule of 30 is not relevant here.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205695e2cc5-6a04-4650-a7cf-3074aae02579.jpg\">",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Ergometrine</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24 year primigravida is admitted to LR at 37 weeks of gestation with history of preeclampsia for induction of labour. She has prolonged labour, delivers a female fetus of 2.8 kg & goes into PPH. Which of the following drugs is contraindicated in the management of PPH in this scenario?</span></p>",
      "unique_key": "DT1289338",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>This drug is contraindicated in patients with preeclampsia or hypertension. It can cause vasoconstriction and potentially increase blood pressure, which is risky for someone with a history of preeclampsia.</p>\r\n<p><strong>Oxytocin (Option a):</strong> This is the <em>first-line treatment for PPH</em>. It helps stimulate uterine contractions to reduce bleeding and is safe for use in patients with preeclampsia.</p>\r\n<p><strong>Carboprost (Option c):</strong> This is a <em>prostaglandin analogue</em> used for PPH that is effective and can be used in cases of preeclampsia, though it <em>should be used cautiously if there are additional contraindications like bronchial asthma, pulmonary HTN, amniotic fluid embolism.</em></p>\r\n<p><strong>Misoprostol (Option d):</strong> This <em>prostaglandin analogue</em> is used to manage PPH and is <em>generally considered safe, even in patients with preeclampsia.</em></p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p><em>Methylergometrine is contraindicated in hypertensive women.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501184beac542-5671-4d02-a24d-e5fdf9ebfa5e.jpg\">",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Ergometrine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G3P2L2 woman reports to LR at 39 weeks of gestation in active labour. She delivers a male fetus of 3.2 kg & has torrential bleeding thereafter. She has a history of bronchial asthma. Which of the following drugs is contraindicated in the management of PPH in this scenario?</span></p>",
      "unique_key": "DT1289339",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289339,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Prostaglandins enhance uterine contractility and cause vasoconstriction.</li>\r\n<li>The prostaglandin most commonly used is <strong>15-Methyl Prostaglandin F 2a or carboprost /Dinoprost(Hemabate).</strong></li>\r\n</ul>\r\n<p><strong>Oxytocin (Option a):</strong> This is the <em>standard first-line treatment for PPH and is safe in patients with bronchial asthma.</em></p>\r\n<p><strong>Ergometrine (Option b):</strong> Generally used for PPH but can cause hypertension and is not ideal if the patient has a history of high blood pressure or cardiovascular issues. However, <em>it is not specifically contraindicated in asthma.</em></p>\r\n<p><strong>Misoprostol (Option d):</strong> This is another prostaglandin analogue used for PPH. It is generally safe and does not have the same risk of bronchoconstriction as Carboprost.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>Carboprost tromethamine (Hemabate) is the 15-methyl derivative of prostaglandin F2&alpha;. It is approved for uterine atony treatment in a <em>dose of 250 ug (0.25 mg) given IM.</em> This dose can be repeated if necessary, at <em>15- to 90-minute intervals up to a maximum of eight doses.</em></p>\r\n<p>Pharmacological effect is <em>pulmonary airway and vascular constriction.</em> Thus, carboprost should not be used for asthmatic women or those with pulmonary hypertension, including women those with suspected amnionic fluid embolism.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothermia, Acidosis & Coagulopathy</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthermia, Acidosis & Coagulopathy</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperpyrexia, Alkalosis & Coagulopathy</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothermia, Alkalosis & Coagulopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lethal triad is a combination of:</span></p>",
      "unique_key": "DT1289340",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289340,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The morbidity and mortality associated with massive PPH is often accompanied by a triad of hypothermia, acidosis and coagulopathy.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412059b19761f-c39c-4d51-86a2-3c44856578c0.jpg\">",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrinolytic</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-fibrinolytic</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterotonic</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasoconstrictive agent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman experiences postpartum hemorrhage (PPH) following a complicated delivery. The healthcare provider decides to administer Tranexamic acid to manage the bleeding. What is the mechanism of action of Tranexamic acid?</span></p>",
      "unique_key": "DT1289341",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289341,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Tranexamic acid is an anti-fibrinolytic agent. It works by inhibiting the breakdown of fibrin, thus helping to stabilize clots and reduce bleeding.</p>\r\n<p><strong>Fibrinolytic (Option a):</strong> Fibrinolytics, such as tissue plasminogen activator (tPA), dissolve clots and are used to treat conditions like stroke or myocardial infarction but are <em>not used in PPH management.</em></p>\r\n<p><strong>Uterotonic (Option c):</strong> Uterotonics, such as oxytocin or ergometrine, are used to stimulate uterine contractions to reduce bleeding but <em>do not affect fibrinolysis.</em></p>\r\n<p><strong>Vasoconstrictive agent (Option d):</strong> Vasoconstrictors can help reduce bleeding by constricting blood vessels, but this is <em>not the primary mechanism of Tranexamic acid.</em></p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>Primary mechanism of Trenexamic acid is as anti fibrinolytic.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">It is available by the brand name of Novo7</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">It acts by binding with tissue factor to augment the extrinsic clotting pathway by activating factor IX and X</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Recommendation associated with its use warrants the correction of hypovolemia, acidosis and thrombocytopenia prior to its use.</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Complications include thromboembolic events</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements are correct regarding the use of recombinant factor VIIa in management of PPH, except:</span></p>",
      "unique_key": "DT1289342",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Recombinant factor VIIa binds with tissue factor to augment the <strong>extrinsic</strong> clotting pathway, <em>primarily by activating factor X directly, not factor IX.</em> It does not significantly affect the intrinsic pathway.</p>\r\n<p><strong>Option a.</strong> Recombinant factor VIIa is marketed under the brand name <em>NovoSeven (Novo7)</em> and is used to manage bleeding in various conditions, including PPH.</p>\r\n<p><strong>Option c.</strong> It is crucial to correct underlying issues such as hypovolemia, acidosis, and thrombocytopenia before administering recombinant factor VIIa to optimize its efficacy and reduce complications.</p>\r\n<p><strong>Option d.</strong> Recombinant factor VIIa can lead to thromboembolic complications, including deep vein thrombosis and pulmonary embolism, due to its potent clotting effects.</p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<ul>\r\n<li>augment the <strong>extrinsic</strong> clotting pathway <em>primarily by activating factor X directly,</em></li>\r\n<li>marketed under the brand name <em>NovoSeven (Novo7)</em></li>\r\n<li>can lead to thromboembolic complications, including deep vein thrombosis and pulmonary embolism, due to its potent clotting effects.</li>\r\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">B-Lynch</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Hayman</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Cho</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Gunshella</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of uterine compression suture:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205bc6d6f2d-8b39-4953-9727-0ea71261ff14.png\"></span></p>",
      "unique_key": "DT1289343",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289343,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>B-Lynch Compression Sutures:</strong> This surgical technique uses a <em>no. 2 chromic suture</em> to compress the <em>anterior and posterior uterine walls together</em> (Christopher B-Lynch, 1997).</p>\r\n<p>Because they give the appearance of suspenders, they are also called braces. They are a modality <strong>to <em>control atonic PPH</em></strong>, <em>with preservation of future fertility too. </em></p>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>Various uterine compression sutures have been described, with the inventor's name being used, such as Hayman, Cho, Pereira, Gunshella etc.</p>\r\n<p>The image below shows B-Lynch, Cho &amp; Hayman uterine compression sutures respectively.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120593d205a2-dcbd-44de-a6d8-a5168227176e.jpg\">",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a longer-acting oxytocin derivative</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Use of carbetocin resulted in a statistically significant reduction in the need for further uterotonics compared with oxytocin for those undergoing a vaginal delivery</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbetocin in the dose of 100 micrograms given as an intravenous bolus over 1 minute should be used for the prevention of PPH in elective caesarean deliveries</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">It is heat stable, so cold chain maintenance is not required</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the incorrect statement regarding this novel drug used to control PPH:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412050613154a-2063-4f52-958b-a6b57c86daa9.jpg\"></span></p>",
      "unique_key": "DT1289344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Use of carbetocin resulted in a statistically significant reduction in the need for further uterotonics compared with oxytocin <em>for those undergoing a caesarean, but not for vaginal delivery.</em></strong></li>\r\n<li>Carbetocin in the dose of <em>100 micrograms</em> given as an <em>intravenous bolus over 1 minute</em> should be used for the prevention of PPH in elective caesarean deliveries</li>\r\n<li>It is a <em>heat stable, longer acting derivative of Oxytocin</em> &amp; does not need cold chain maintenance but it is advised to store it at &lt; 30 degree Celsius.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<ul>\r\n<li>Carbetocin(Duratocin), a long-acting oxytocin analogue, is available and effective for hemorrhage prevention. Prescribing information for carbetocin cites its use for cesarean delivery.</li>\r\n<li>100ug I/v over 1 minute</li>\r\n</ul>\r\n<p><strong>Reference:</strong> RCOG Green Top Guideline no. 52 Prevention and Management of Postpartum Haemorrhage</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">>300 ml</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">>500 ml</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">>1000 ml</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">>1500 ml</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32 year old multigravida comes to LR in the second stage of labour, She delivers a depressed neonate & immediately after removal of placenta there is ongoing blood loss. Her systolic blood pressure is below 80 mmHg, associated with worsening tachycardia, tachypnoea and altered mental state. What could be the average estimated blood loss?</span></p>",
      "unique_key": "DT1289345",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Clinical signs and symptoms of hypovolaemia should be included in the assessment of PPH.</li>\r\n<li>However, clinicians should be aware that the physiological increase in circulating blood volume during pregnancy means that the signs of hypovolaemic shock become less sensitive in pregnancy.</li>\r\n<li>In pregnancy, pulse and blood pressure are usually maintained in the normal range until blood loss exceeds 1000 ml; tachycardia, tachypnoea and a slight recordable fall in systolic blood pressure occur with blood loss of 1000-1500 ml.</li>\r\n<li>A systolic blood pressure below 80 mmHg, associated with worsening tachycardia, tachypnoea and altered mental state, usually indicates a PPH in excess of 1500 ml</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205deba0a25-923c-4517-9dbe-7b1d60e6eb43.jpg\">\r\n<p><strong>Reference:</strong> RCOG Green Top Guideline no. 52 Prevention and Management of Postpartum Haemorrhage</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Bakri balloon</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Sengstaken Blakemore balloon</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Rusch balloon</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Condom catheter balloon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the following used in the management of PPH:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205f172e3c0-f2a2-4c52-b285-b31829caa90e.jpg\"></span></p>",
      "unique_key": "DT1289346",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289346,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Bakri balloon, discovered in 1992 by Bakri, which is made up of 100% silicone (without latex) as shown in the figure with a ductile shape that allows it to conform to the uterine anatomy. It is <em>used for Uterine Balloon Tamponade.</em></li>\r\n<li>It has a probe with two pathways: One for balloon inflation and the other to drain the uterine cavity (occult bleeding), where it allows the application of <em>up to 500 g of traction tension.</em></li>\r\n<li>Once deflated it is very easy to remove, so it is considered as a <em>non-surgical procedure.</em></li>\r\n<li>In addition to the catheter, a 50 mL syringe, drainage bag, saline solution (500 mL), Foley catheter, and antiseptic gauze for vaginal plug are required.</li>\r\n<li>It can be inserted transvaginally or abdominally, depending on the type of delivery</li>\r\n<li>It is used to provide <strong><em>temporary control or reduction of postpartum haemorrhage</em></strong> when conservative management is warranted</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p><strong>Bakri balloon catheter is method of uterine tamponade.</strong></p>\r\n<p><strong>Non surgical management of PPH.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412054730d41e-e468-48aa-be69-b5d5b99c39e1.jpg\">",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolapse</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine inversion</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibroid polyp</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta accrete spectrum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A multigravida presents to LR with the following picture after a home delivery by an untrained birth attendant. Her BP 90/60 mmHg, Pulse 132bpm, RR 24/min. Foley's catheterization is done & supportive management started. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120564ef445b-45c9-42e1-a265-ba5762d7a839.png\"></span></p>",
      "unique_key": "DT1289347",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>This is a case of complete uterine inversion.</strong></p>\r\n<ul>\r\n<li>It is an <em>extremely rare but a life-threatening complication in third stage</em> in which the uterus is turned inside out partially or completely.</li>\r\n<li>The obstetric inversion is almost always an acute one and usually complete.</li>\r\n</ul>\r\n<p><strong>DIAGNOSIS:</strong></p>\r\n<p>Symptoms: Acute lower abdominal pain with bearing down sensation.</p>\r\n<p><strong>Signs:</strong></p>\r\n<ol>\r\n<li>(1) <em>Varying degree of shock is a constant feature</em></li>\r\n<li>(2) Abdominal examination-\r\n<ol style=\"list-style-type: lower-alpha;\">\r\n<li><em>Cupping or dimpling of the fundal surface,</em></li>\r\n<li><em>Bimanual examination not only helps to confirm the diagnosis but also the degree</em>. In complete variety, a pear-shaped mass protrudes outside the vulva with the broad end pointing downward and looking reddish purple in colour.</li>\r\n<li><em>Sonography can confirm the diagnosis when clinical examination is not clear.</em></li>\r\n</ol>\r\n</li>\r\n</ol>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501189b65686c-fdaf-4fde-b22c-5ace4c32493f.jpg\">\r\n<p><strong>Option a. Prolapse</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Uterine or pelvic organ prolapse typically <em>presents with a sensation of heaviness or bulging in the vaginal area</em>, but it is less likely to cause acute hypotension and tachycardia immediately after delivery.</li>\r\n</ul>\r\n<p><strong>Option c. Fibroid polyp</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: While fibroid polyps can protrude into the vagina and cause bleeding, they are <em>not typically associated with the severe hemodynamic instability described here.</em></li>\r\n</ul>\r\n<p><strong>Option d. Placenta accreta spectrum</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Placenta accreta spectrum refers to abnormal placental attachment to the uterine wall, which can lead to severe postpartum hemorrhage. However, uterine inversion is more likely in this scenario due to the acute hemodynamic collapse described.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<ul>\r\n<li>This is due to the <em>mismanagement of third stage of labor</em>. - Pulling the cord when the uterus is atonic especially when combined with fundal pressure - Fundal pressure while the uterus is relaxed-Faulty technique in manual removal.</li>\r\n<li>Spontaneous (40%):<em>Fundal attachment of the placenta (75%),</em> short cord and placenta accreta, weakness of uterine wall at the placental site are often associated.</li>\r\n<li><em>Leads to significant blood loss and circulatory shock,</em> as indicated by the low BP (90/60 mmHg), tachycardia (Pulse 132 bpm), and tachypnea (RR 24/min).</li>\r\n</ul>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbetocin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Uterotonic of choice in AMTSL:</span></p>",
      "unique_key": "DT1289359",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>AMTSL should only be done by SBA/trained staff.</li>\r\n<li><strong>Oxytocin remains the uterotonic of choice for AMTSL.</strong></li>\r\n<li>In settings where oxytocin is unavailable, oral misoprostol (600 &mu;g) is recommended.</li>\r\n</ul>\r\n<p>In the context of <strong>Active Management of the Third Stage of Labor (AMTSL)</strong>, the uterotonic of choice is <strong>oxytocin. OPTION</strong></p>\r\n<p><strong>a. Misoprostol</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Misoprostol, a prostaglandin analogue, is used as an <em>alternative in settings where oxytocin is not available</em> or when refrigeration (for oxytocin) is an issue. However, oxytocin remains the first-line uterotonic in AMTSL.</li>\r\n</ul>\r\n<p><strong>c. Carboprost</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Carboprost, a prostaglandin, is used <em>in cases of refractory PPH, but it is not the first choice in AMTSL</em> due to its side effect profile (e.g., nausea, vomiting, bronchospasm).</li>\r\n</ul>\r\n<p><strong>OPTION d. Carbetocin</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Carbetocin, a long-acting oxytocin analogue, may be <em>used in specific cases such as after cesarean deliveries</em>. However, oxytocin is still the preferred uterotonic in routine AMTSL for vaginal deliveries.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<ul>\r\n<li>Oxytocin is the <strong>first-line uterotonic agent</strong> recommended in AMTSL due to its effectiveness, safety, and quick onset in promoting uterine contractions to prevent postpartum hemorrhage (PPH).</li>\r\n<li>Active management of third-stage labor:</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412050dd3a647-d15e-4531-aefb-be2add41f88d.jpg\">\r\n<p><strong>Reference:</strong> Guidance Note on Prevention &amp; Management of Postpartum Haemorrhage by MoHFW</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Bimanual uterine compression</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">External aortic compression</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine packing</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine artery embolization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Use of which of the following modalities is not recommended by MoHFW for the management of atonic PPH?</span></p>",
      "unique_key": "DT1289360",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289360,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Use of bimanual uterine compression &amp; external aortic compression for the treatment of PPH due to uterine atony after vaginal birth.</li>\r\n<li><strong>The use of uterine packing is not recommended for the treatment of PPH due to uterine atony after vaginal birth.</strong></li>\r\n<li>The use of uterine artery embolization is recommended as a treatment for PPH due to uterine atony, if other measures have failed.</li>\r\n<li>If bleeding does not stop in spite of treatment (using uterotonics and other available interventions), the use of surgical interventions (Modified B-Lynch) is recommended.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120533d50998-10a4-42e6-a9e1-3f747d7fb5fa.jpg\">\r\n<p><strong>Reference:</strong> Guidance Note on Prevention &amp; Management of Postpartum Haemorrhage by MoHFW</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Keep the woman warm</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue uterine massage during transport</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Provide bimanual uterine compression</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevate head end to improve blood supply to vital organs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are to be done while transporting a woman who has PPH to a higher center, except:</span></p>",
      "unique_key": "DT1289361",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Elevate head end to improve blood supply to vital organs</strong></p><p><strong>Incorrect</strong>: Elevating the <strong>head end</strong> is not advised in cases of PPH. Instead, the <strong>head should be lowered</strong>, and the <strong>legs elevated (Trendelenburg position)</strong> to maintain adequate perfusion to vital organs during hypovolemic shock.</p><p><strong>KEY TAKE AWAY:</strong></p><p><strong><em><u>Recommendations to be followed while transporting a woman who is bleeding</u></em></strong></p><ul><li><em>Elevate legs to improve blood supply to vital organs</em></li><li>Keep the woman warm</li><li>Send a skilled provider with the woman to ensure an open airway, to deliver first aid if the woman goes into shock</li><li>Continue uterine massage during transport Provide bimanual uterine compression (external if possible and internal if necessary)</li></ul><p><strong>Reference:</strong> Guidance Note on Prevention &amp; Management of Postpartum Haemorrhage by MoHFW</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Ringer Lactate</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">5% Dextrose</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">DNS</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Isolyte M</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fluid of choice for resuscitation in hypovolemic shock due to PPH:</span></p>",
      "unique_key": "DT1289362",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Almost all circulatory <a href=\"https://www.msdmanuals.com/en-in/professional/critical-care-medicine/shock-and-fluid-resuscitation/shock\">shock</a> states require large-volume IV fluid replacement, as does severe intravascular volume depletion due to PPH.</li>\r\n<li>Intravascular volume deficiency is acutely compensated for by vasoconstriction, followed over hours by migration of fluid from the extravascular compartment to the intravascular compartment, maintaining circulating volume at the expense of total body water.</li>\r\n<li><em>Crystalloid solutions for intravascular volume replenishment are typically isotonic</em> (eg, 0.9% saline or Ringer's lactate). Water freely travels outside the vasculature, so as little as 10% of isotonic fluid remains in the intravascular space.</li>\r\n<li>With hypotonic fluid (eg, 0.45% saline), even less remains in the vasculature, and, thus, this fluid is not used for resuscitation.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p><strong>Both 0.9% saline and Ringer's lactate are equally effective; <em>Ringer's lactate may be preferred in hemorrhagic shock because it somewhat minimizes acidosis and will not cause hyperchloremia.</em></strong></p>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine artery</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian artery</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">External iliac artery</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal iliac artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following arteries is not ligated in stepwise devascularisation of pelvis for management of atonic PPH?</span></p>",
      "unique_key": "DT1289363",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289363,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205cdebf12a-4146-45b7-82b4-412705f47dda.jpg\">\r\n<ul>\r\n<li>Ligation of the external iliac artery produces an acutely ischemic leg which classically presents with the absence of distal pulses and whiteness or pallor of the foot.</li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<ul>\r\n<li>External iliac artery is not lighted as it supplies Lower limb.</li>\r\n<li>Internal iliac artery is ligated .</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205d815f6f2-af1e-4925-a900-c23dcdd2a89b.jpg\">",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior division of internal iliac artery is ligated</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulse pressure reduces by ~85% distal to the ligation</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Collateral circulation develops soon after ligation</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal iliac vein & ureter are at risk of injury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman lands in PPH after delivery. Medical management fails. She is rushed to OT & uterine compression sutures are applied. Bleeding still continues. Decision to go for internal iliac artery ligation is taken. Which of the following statements is false regarding this procedure?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241205022bb51f-1d38-4717-a5d9-8bb81290d25f.jpg\"></span></p>",
      "unique_key": "DT1289366",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The <strong>anterior division</strong> of the internal iliac artery is the one that is ligated in this procedure, not the posterior division. The anterior division supplies most of the pelvic organs, and ligating it reduces blood flow to the uterus.</p>\r\n<p><strong>OPTION b. Pulse pressure reduces by ~85% distal to the ligation</strong></p>\r\n<ul>\r\n<li><strong>Correct</strong>: Ligation of the internal iliac artery reduces pulse pressure in the uterine circulation by approximately 85%, which <em>helps in controlling bleeding.</em></li>\r\n</ul>\r\n<p><strong>OPTION c. Collateral circulation develops soon after ligation</strong></p>\r\n<ul>\r\n<li><strong>Correct</strong>: Collateral circulation through other pelvic vessels develops quickly after ligation, <em>ensuring that vital pelvic organs still receive blood supply despite the ligation.</em></li>\r\n</ul>\r\n<p><strong>OPTION d. Internal iliac vein &amp; ureter are at risk of injury</strong></p>\r\n<ul>\r\n<li><strong>Correct</strong>: The <strong>internal iliac vein</strong> and <strong>ureter</strong> are indeed at risk during this procedure <em>because of their close proximity to the internal iliac artery.</em></li>\r\n</ul>\r\n<p><strong>KEY TAKE AWAY:</strong></p>\r\n<p>Anterior division of internal iliac artery supplies uterus.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412056e37ce57-6a6c-4e4c-b8f5-2d6c8376724d.jpg\">",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}